ARTICLE | Clinical News
MN rgp160 AIDS vaccine: Started Phase I/II trials
June 21, 1993 7:00 AM UTC
Immuno-U.S. Inc. Product: MN rgp160 AIDS vaccine Indication: HIV-positive asymptomatic patients with CD4 counts >500 Status: Started Phase I/II trials in U.S. and Europe ...